Theralink Technologies, Inc.

Biotechnology ResearchColorado, United States2-10 Employees

Theralink Technologies, Inc. is a biotechnology research company based in Golden, Colorado, focused on precision oncology. Drawing on more than 16 years of development, it aims to move beyond genomic and transcriptomic data by measuring the activation state of drug target proteins and their signaling partners within tumor tissue, providing a quantitative protein- and phosphoprotein-based assay to inform treatment decisions. The company positions its work as a decision-support tool for physicians, helping to identify therapies that are more likely to elicit responses in individual patients and to support clinical trials in oncology.

Theralink serves oncologists and biopharma researchers seeking deeper molecular insights to guide targeted therapy choices across solid tumors. Its work encompasses a portfolio of protein biomarkers that relate to current FDA-approved therapies and certain investigational drugs, with a broader ambition to develop assays applicable to multiple tumor types. Recent activity noted in public outlets includes asset transactions related to continuing precision medicine efforts under new ownership. The organization operates as a small team within the biotechnology research sector, dedicated to advancing phosphoprotein-based measurement to inform oncology care.

Sign up for free to view info

Email Format Employee directory